Clinical Outcomes of a Treatment for Mild Cases of COVID-19 using a Polyherbal Concoction based on Thai Traditional Medicine: A Retrospective Chart Review
Article Sidebar
Main Article Content
Abstract
Dating back to the COVID-19 pandemic, herbal medicine gained prominence as a potential means of managing the virus. However, published evidence supporting its efficacy remains limited. Vaccines and antiviral drugs undoubtedly constitute the primary defense against viral threats. However, herbal medicine remains a viable option for management in addressing future viral outbreaks. This study undertakes a retrospective analysis of 101 charts of patients who solely used an herbal concoction based on Thai traditional medicine for COVID-19 treatment in a local clinic. The concoction comprised a combination of 13herbs selected from two distinct formulas, Ya-ha-rak, Prasaporhyai, and other herbs. The findings indicate no fatality or health complications associated with the treatment. Concerning clinical outcome, nearly all patients achieved negative laboratory results for COVID-19 in less than two weeks, except for two individuals whose conditions did not improve within a two-week timeframe. These two patients opted to discontinue the current treatment to pursue alternative therapies. Notably, none exhibited pneumonia symptoms. Thus, this herbal approach seems safe and beneficial for mild COVID-19 cases. This is the first human clinical report on the antiviral properties of a formulation comprising principal medicinal plants sourced from Ya-ha-rak and Prasaporhyai. This study, though constrained by its inability to distinguish between patients who could recover without necessitating medical intervention, was conducted with the aspiration that it will trigger further advancement and investigations into the efficacy and safety of antiviral herbs, thereby enhancing our understanding and utilization of these natural resources.
Article Details
References
Jindahra P, et al (2022). Demographic and initial outbreak patterns of COVID-19 in Thailand. Journal of Population Research. 39(4), 567–88.
Rajatanavin N, et al. (2021). Responding to the COVID-19 second wave in Thailand by diversifying and adapting lessons from the first wave. BMJ Global Health.6(7), e006178.
Ang L, et al. (2022). Herbal medicine for COVID-19: An overview of systematic reviews and meta-analysis. Phytomedicine. 102, 154136.
Luo H, et al. (2021). Characteristics of registered clinical trials on traditional Chinese medicine for coronavirus disease 2019 (COVID-19): A scoping review. European Journal of Integrative Medicine. 41, 101251.
Ren W, et al. (2021). Research advance on Qingfei Paidu Decoction in prescription principle, mechanism analysis and clinical application. Frontiers in Pharmacology. 11, 2046.
Xiao M, et al. (2020). Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial. Pharmacological Research. 161, 105126.
Benjaponpithak A, et al. (2021). Short communication on use of Andrographis herb (Fathalaich on) for the treatment of COVID-19patients. Journal of Thai Traditional and Alternative Medicine. 19(1), 229–233.
Department of Medical Services, Ministry of Public Health [Thailand]. COVID-19 CPG for healthcare workers (updated 21 March 2022).[cited 2023 Mar 11], retrieved from: https://ddc.moph.go.th/viralpneumonia/eng/file/guidelines/g_CPG_22Mar22.pdf.
Subcharoen P. (1994). Samudhana-vinijjaya scripture [In Thai]. Bangkok: The War Veterans Organization of Thailand printing.
Wat phra chetuphon wimon mangkhalaram rajwaramahawihan’s traditional medicine school. (1961). Paet-sat-song-krao, volume 2 [In Thai]. Bangkok: Mahamakut Buddhist university.
The Fine Arts Department. (1999). Royal medical textbook, 5th Reign, volume 1 [In Thai].Bangkok: The Fine Arts Department.
Rarueysong S. (2021). Thailand’s Justice Ministry speeds up production of Fah talaijone tablets to tackle shortage. [Internet]. National News Bureau of Thailand., retrieved from:https://thainews.prd.go.th/en/news/detail/TCATG210816112410600.
Ministry of Public Health [Thailand]. (2020). National List of Essential Medicines: Herbal Medicine Directory [In Thai]. [cited 2023 Mar 11], retrieved from: https://ttm.skto.moph.go.th/document_file/pr008.pdf.
The Medical Council of Thailand. (2020). Telemedicine and online clinic guidelines [In Thai]. Thai Government Gazette. 137(Special 166 Ngor), 52–54.
Matt V, and Matthew H. (2013). The retrospective chart review: important methodological considerations. Journal of Educational Evaluation for Health Professions. 10, 12.
Puenpa J, et al. (2023). Molecular characterisation and tracking of severe acute respiratory syndrome coronavirus 2 in Thailand, 2020–2022. Archives of Virology. 168(1), 1–10.
Chien TJ, et al. (2022). Therapeutic effects of herbal-medicine combined therapy for COVID-19: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Pharmacology. 13:950012.
Demeke CA, et al. (2021). Herbal medicine use for the management of COVID-19: A review article. Metabolism Open. 12, 100141.
National Drug Committee, Ministry of Public Health. (2021). Thai National List of Essential Medicines 2021 May 31. [cited 2023Oct19], retrieved from: https://ndi.fda.moph.go.th/index.php/ndi_news_detail/index/220.
World Health Organization. (2023). Coronavirus disease (COVID-19). [Internet]. [cited 2023 Dec 10], retrieved from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19
Kar P, et al. (2022). Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation. Journal of Biomolecular Structure & Dynamics. 39(13):1.
Yu R, et al. (2020). Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking. International Journal of Antimicrobial Agents. 56(2):106012.
van de Sand L, et al. (2021). Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease. Viruses. 13(4).
Radapong S, et al. (2022). Anti-SARS-CoV-2 activity screening of the selected Thai medicinal plants and potential host-target molecules. Bulletin of the Department of Medical Sciences. 64(2):93–105.
Choonong R, et al. (2022). Evaluating the in vitro efficacy of Quassinoids from Eurycoma longifolia and Eurycoma harmandiana against common cold human coronavirus OC43 and SARS-CoV-2 Using In-cell enzyme-linked immunosorbent assay. Journal of Natural Products. 85(12):2779–88.
Radapong S, et al. (2022). Anti-SARS-CoV-2 activity and Inhibition of ACE2 and TMPRSS2 expression of Ya Prasa Pro Yai, Ya Ha Rak and Ya Chanthalila traditional drug formulas [In Thai]. Bulletin of the Department of Medical Sciences. 64(2), 93–105.
Beyerstedt S, et al. (2021). COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. European Journal of Clinical Microbiology & Infectious Diseases. 40(5):905.
Hoffmann M, et al. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 181(2):271-280.e8.
Makchuchit S. (2010). Anti-inflammatory and anti-allergic activities of Thai traditional medicine preparation called Prasaprohyai. [M.Sc.Med.]: Thammasat University.
Juckmeta T, and Itharat A. (2012). Anti-inflammatory and antioxidant activities of Thai traditional medicine remedy called “Ya-Ha-Rak.” Journal of Health Research. 26(4).
Kim HP, et al. (1998). Effects of naturally-occurring flavonoids and biflavonoids on epidermal cyclooxygenase and lipoxygenase from guinea-pigs. Prostaglandins, Leukotrienes and Essential Fatty Acids. 58(1):17–24.
Anand David AV, et al. (2016). Overviews of biological importance of quercetin: A bioactive flavonoid. Pharmacognosy Reviews. 10(20):84.
Li Y, et al. (2016). Quercetin, inflammation and immunity. Nutrients. 8(3).
Liu B, et al. (2018). Protective effects of dietary luteolin against mercuric chloride-induced lung injury in mice: Involvement of AKT/Nrf2 and NF-κB pathways. Food and Chemical Toxicology. 113:296–302.
Chen X, et al. (2012). Kaempferol regulates MAPKs and NF-κBsignaling pathways to attenuate LPS-induced acute lung injury in mice. International Immunopharmacology. 14(2):209–16.
Koonrungsesomboon N, et al. (2014). Therapeutic potential and pharmacological activities of Atractylodes lancea (Thunb.) DC. Asian Pacific Journal of Tropical Medicine. 7(6):421–8.
Jun X, et al. (2018). Pharmacological effects of medicinal components of Atractylodes lancea (Thunb.) DC. Chinese Medicine.13(1):59.
Resch M, et al. 5-(1998). Lipoxygenase and cyclooxygenase-1 inhibitory active compounds from Atractylodes lancea. Journal of Natural Products. 61(3):347–50.
Hossen MJ, et al. (2021). The anti-inflammatory effects of an ethanolic extract of the rhizome of Atractylodes lancea, involves Akt/NF-κBsignaling pathway inhibition. Journal of Ethnopharmacology. 277:114183
Thakkar AN, et al. (2020). Cardiovascular implications of COVID-19 infections. Methodist De Bakey Cardiovascular Journal. 16(2):146.
Tungmunnithum D, et al. (2020). A critical cross-species comparison of pollen from Nelumbo nucifera Gaertn. vs. Nymphaea lotus L. for authentication of Thai medicinal herbal tea. Plants (Basel). 9(7):921.
Tungmunnithum D, et al. (2022). Flavonoids from sacred lotus stamen extract slows chronological aging in yeast model by reducing oxidative stress and maintaining cellular metabolism. Cells. 11(4):599.
Hyun AJ, et al. (2003). Antioxidant principles of Nelumbo nucifera stamens. Archives of Pharmacal Research. 26(4):279–85.
Zheng S, et al. (2022). Systematic review of Lonicerae Japonicae Flos: A significant food and traditional Chinese medicine. Frontiers in Pharmacology. 13:1013992.
Shan J, et al. (2009). Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-kappa B and JNK/AP-1 activation. International Immunopharmacology. 9(9):1042–8.
Potduang B, et al. (2007). Biological activities of Schefflera Leucantha. African Journal of Traditional, Complementary and Alternative Medicines. 4(2):157.
Pancharoen O, et al. (1994). Triterpenoid glycosides from Schefflera lucantha. Phytochemistry. 35(4):987–92.
Wang Y, et al. (2021). The genus Schefflera: A review of traditional uses, phytochemistry and pharmacology. Journal of Ethnopharmacology. 279:113675.
Department of Thai Traditional and Alternative Medicine Ministry of Public Health [Thailand]. (2021). Guidelines for using Thai traditional medicine in the care of COVID-19 patients [In Thai]. 1st ed Bangkok: N.S.S. Creation Part., Ltd.
World Health Organization, Africa Region. (2020). WHO supports scientifically-proven traditional medicine. [cited 2023 Jul 8], retrieved from: https://www.afro.who.int/news/who-supports-scientifically-proven-traditional-medicine
